Reset filter
Trefwoorden
Svulster i eggleder ×
Meer tonen Trefwoorden
Inhoudsopgave
  1. 1. Klinische studie
  2. 2. Routinedocumentatie
  3. 3. Register-/kohortstudies
  4. 4. Kwaliteitswaarborging
  5. 5. Datastandaard
  6. 6. Patiëntenvragenlijst
  7. 7. Medisch vakgebied
Geselecteerde datamodellen

U moet ingelogd zijn om meerdere datamodellen te selecteren en die te downloaden of te analyseren.

113 Zoekresultaten.
Relevantie Beoordeling Nieuwe eerst Oude eerst

Eligibility Fallopian Tube Cancer NCT01079832

- 21-03-18 - 1 Formulier, 1 Itemgroep, 11 Data-elementen, 1 Taal
Itemgroep: Criteria
Stereotactic Radiosurgery Using CyberKnife in Treating Women With Advanced or Recurrent Gynecological Malignancies; ODM derived from: https://clinicaltrials.gov/show/NCT01079832

Fallopian Tube Cancer NCT00951496 On-Study - GOG-0252 Primary Ovarian Cancer - On Study Form - 2835512v1.0 - GOG-0252 Primary Ovarian Cancer - On Study Form

- 09-01-15 - 1 Formulier, 5 Itemgroepen, 26 Data-elementen, 1 Taal
Itemgroepen: HEADER MODULE, OVARIAN: DISEASE DESCRIPTION, OVARIAN: FINDINGS FROM PRIMARY SURGERY, OVARIAN: POST-OPERATIVE FINDINGS FOLLOWING PRIMARY SURGERY, COMMENTS
GOG-0252 Primary Ovarian Cancer - On Study Form Bevacizumab and Intravenous or Intraperitoneal Chemotherapy in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=62457734-8B2A-C973-E040-BB89AD430DDB

Fallopian Tube Cancer NCT01167712 On-Study - GOG-0262: Primary Ovarian Cancer - On Study Form - 2918240v1.0 - GOG-0262: Primary Ovarian Cancer - On Study Form

- 09-01-15 - 1 Formulier, 5 Itemgroepen, 26 Data-elementen, 1 Taal
Itemgroepen: HEADER MODULE, OVARIAN: DISEASE DESCRIPTION, OVARIAN: FINDINGS FROM PRIMARY SURGERY, OVARIAN: POST-OPERATIVE FINDINGS FOLLOWING PRIMARY SURGERY, COMMENTS
GOG-0262: Primary Ovarian Cancer - On Study Form Paclitaxel and Carboplatin With or Without Bevacizumab in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=6E60272A-2D16-BA9E-E040-BB89AD434554

Fallopian Tube Cancer NCT00262847 On-Study - GOG-0218 Primary Ovarian Cancer - On Study Form - 2303628v3.0 - GOG-0218 Primary Ovarian Cancer - On Study Form

- 09-01-15 - 1 Formulier, 6 Itemgroepen, 28 Data-elementen, 1 Taal
Itemgroepen: HEADER MODULE, OVARIAN: DISEASE DESCRIPTION, OVARIAN: FINDINGS FROM PRIMARY SURGERY, OVARIAN: POST-OPERATIVE FINDINGS FOLLOWING PRIMARY SURGERY, COMMENTS, FOOTER MODULE
GOG-0218 Primary Ovarian Cancer - On Study Form Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal Cancer, or Fallopian Tube Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=F0E13298-CD9B-5802-E034-0003BA3F9857

Fallopian Tube Cancer NCT00951496 On-Study - GOG-0252 Ovarian Cancer Surgery Reporting (OCR) - 2839109v1.0 - GOG-0252 Ovarian Cancer Surgery Reporting (OCR)

- 09-01-15 - 1 Formulier, 4 Itemgroepen, 53 Data-elementen, 1 Taal
Itemgroepen: HEADER MODULE, Ovarian Cancer Surgery, Surgery Information, Surgery Information2
GOG-0252 Ovarian Cancer Surgery Reporting (OCR) Bevacizumab and Intravenous or Intraperitoneal Chemotherapy in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=62BEE31D-C4C9-F3A9-E040-BB89AD434182

Fallopian Tube Cancer NCT01081262 On-Study - GOG-0241 Recurrent Gynecologic Cancer - On Study Form (OSR) - 3127560v1.0 - GOG-0241 Recurrent Gynecologic Cancer - On Study Form (OSR)

- 09-01-15 - 1 Formulier, 5 Itemgroepen, 32 Data-elementen, 1 Taal
Itemgroepen: HEADER MODULE, DISEASE DESCRIPTION - PRIOR HISTORY, DISEASE DESCRIPTION - CURRENT HISTORY, PRIOR TREATMENT FOR GYNECOLOGIC CANCER, Comments Module
GOG-0241 Recurrent Gynecologic Cancer - On Study Form (OSR) Carboplatin and Paclitaxel or Oxaliplatin and Capecitabine, With or Without Bevacizumab, as First-Line Therapy in Treating Patients With Newly Diagnosed Stage II, Stage III, Stage IV, or Recurrent Stage I Epithelial Ovarian Cancer or Fallopian Tube Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=8D189316-59D5-8D82-E040-BB89AD433C8E

Fallopian Tube Cancer NCT01081262 On-Study - GOG-0241 Primary Ovarian Cancer - On Study Form (OSO) - 3126804v1.0 - GOG-0241 Primary Ovarian Cancer - On Study Form (OSO)

- 09-01-15 - 1 Formulier, 5 Itemgroepen, 26 Data-elementen, 1 Taal
Itemgroepen: HEADER MODULE, OVARIAN: DISEASE DESCRIPTION, OVARIAN: FINDINGS FROM PRIMARY SURGERY, OVARIAN: POST-OPERATIVE FINDINGS FOLLOWING PRIMARY SURGERY, COMMENTS
GOG-0241 Primary Ovarian Cancer - On Study Form (OSO) Carboplatin and Paclitaxel or Oxaliplatin and Capecitabine, With or Without Bevacizumab, as First-Line Therapy in Treating Patients With Newly Diagnosed Stage II, Stage III, Stage IV, or Recurrent Stage I Epithelial Ovarian Cancer or Fallopian Tube Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=8D17F7CB-7001-90BC-E040-BB89AD435566

Fallopian Tube Cancer NCT00262847 On-Study - GOG-0218 Primary Ovarian Cancer - Medical History Form - 2480320v1.0 - GOG-0218 Primary Ovarian Cancer - Medical History Form

- 09-01-15 - 1 Formulier, 6 Itemgroepen, 7 Data-elementen, 1 Taal
Itemgroepen: HEADER MODULE, Medical History, Autoimmune Disease, Gastrointestinal Tract, Gastrointestinal History2, COMMENTS
GOG-0218 Primary Ovarian Cancer - Medical History Form Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal Cancer, or Fallopian Tube Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=12F90295-11E7-7122-E044-0003BA3F9857

Ovarian Cancer Registration SWOG S0904 NCT00872989 - Registration Worksheet Ovarian Cancer NCT00872989

- 20-05-15 - 1 Formulier, 2 Itemgroepen, 6 Data-elementen, 1 Taal
Itemgroepen: SWOG Patient ID, Patient Information
Southwest Oncology Group S0904 Registration Worksheet for OPEN - Step 2 Docetaxel With or Without Vandetanib in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer NCT00872989 Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=7C965708-98F3-5904-E040-BB89AD432C8B

dbGaP phs000942 Use of WGS for Diagnosis and Discovery in the Cancer Genetics Clinic - Eligibility

- 27-11-24 - 5 Formulieren, 1 Itemgroep, 1 Data-element, 1 Taal
Itemgroep: IG.elig
Principal Investigator: Theodora S. Ross, MD, PhD, Department of Internal Medicine, UT Southwestern Medical Center, Dallas, TX, USA, and Department of Cancer Genetics, UT Southwestern Medical Center, Dallas, TX, USA MeSH: Neoplasms,Breast Neoplasms,Ovarian Neoplasms,Peritoneal Neoplasms,Skin Neoplasms,Esophageal Neoplasms,Thyroid Neoplasms,Urinary Bladder Neoplasms,Endometrial Neoplasms,Fallopian Tube Neoplasms,Melanoma,Testicular Neoplasms,Bile Duct Neoplasms,Lung Neoplasms,Colonic Neoplasms,Adrenocortical Carcinoma,Carcinoma, Renal Cell,Colonic Polyps,Adenomatous Polyposis Coli,Lymphoma, Large B-Cell, Diffuse,Pheochromocytoma,Paraganglioma,Leiomyoma,Hemangioblastoma,Hyperparathyroidism,Pancreatic Neoplasms,Vulvar Neoplasms,Brain Neoplasms,Liver Neoplasms,Kidney Neoplasms,Prostatic Neoplasms,Glioblastoma,Oncocytoma, renal https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000942 Despite the potential of whole-genome sequencing (WGS) to improve patient diagnosis and care, the empirical value of WGS in the cancer genetics clinic is unknown. We performed WGS on members of two cohorts of cancer genetics patients: those with BRCA1/2 mutations (n = 176) and those without (n = 82). Initial analysis of potentially pathogenic variants (PPVs, defined as nonsynonymous variants with allele frequency 1% in ESP6500) in 163 clinically-relevant genes suggested that WGS will provide useful clinical results. This is despite the fact that a majority of PPVs were novel missense variants likely to be classified as variants of unknown significance (VUS). Furthermore, previously reported pathogenic missense variants did not always associate with their predicted diseases in our patients. This suggests that the clinical use of WGS will require large-scale efforts to consolidate WGS and patient data to improve accuracy of interpretation of rare variants. While loss-of-function (LoF) variants represented only a small fraction of PPVs, WGS identified additional cancer risk LoF PPVs in patients with known BRCA1/2 mutations and led to cancer risk diagnoses in 21% of non-BRCA cancer genetics patients after expanding our analysis to 3209 ClinVar genes. These data illustrate how WGS can be used to improve our ability to discover patients' cancer genetic risks. "Reprinted from doi:10.1016/j.ebiom.2014.12.003, with permission from EBioMedicine."

pht004834.v1.p1

1 Itemgroep 5 Data-elementen

pht004835.v1.p1

1 Itemgroep 5 Data-elementen

pht004836.v1.p1

1 Itemgroep 16 Data-elementen

pht004837.v1.p1

1 Itemgroep 5 Data-elementen

Cycle Dose Drug Form Fallopian Tube Cancer (NCT00262847)

- 09-01-15 - 1 Formulier, 3 Itemgroepen, 38 Data-elementen, 1 Taal
Itemgroepen: HEADER MODULE, TREATMENT CYCLE AND MODIFICATION, Pretreatment hematology and chemistry values
GOG-0218 Cycle Dose Drug Form Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal Cancer, or Fallopian Tube Cancer NCT00262847 Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=F11B7C47-A6FE-54E9-E034-0003BA3F9857

Breast Cancer NCT01306032 Registration - Eligibility/Pre-Registration Worksheet - 3158687v1.0 - Eligibility/Pre-Registration Worksheet

- 09-01-15 - 1 Formulier, 6 Itemgroepen, 61 Data-elementen, 1 Taal
Itemgroepen: STANDARD PATIENT IDENTIFIER, STANDARD DEMOGRAPHICS (II), INCLUSION CRITERIA, EXCLUSION CRITERIA, Pre Study Evaluations, Laboratory studies will be conducted 1 week prior to starting study drug will include
Eligibility/Pre-Registration Worksheet ABT-888 With Cyclophosphamide in Refractory BRCA-Positive Ovarian, Primary Peritoneal or Ovarian High-Grade Serous Carcinoma, Fallopian Tube Cancer, Triple-Negative Breast Cancer, and Low-Grade Non-Hodgkin's Lymphoma Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=94CE0410-6594-C0F7-E040-BB89AD4342BD

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial